Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases
about
Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatmentB-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)
P2860
Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@ast
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@en
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@nl
type
label
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@ast
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@en
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@nl
prefLabel
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@ast
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@en
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@nl
P2093
P2860
P356
P1433
P1476
Preponderance of the oncogenic ...... aneous/subcutaneous metastases
@en
P2093
Axel Benner
Hjalmar Kurzen
Judith Hassanzadeh
Marianne Thome
Martin Deichmann
Martin Kirschner
P2860
P2888
P356
10.1186/1471-2407-5-58
P407
P577
2005-06-03T00:00:00Z
P5875
P6179
1005115718